Experiments reveal that C-nucleosides reduce nucleophilicity and slow RNA degradation by altering chemical reactivity, indicating potential therapeutic benefits.
Nucleotides with carbon substitution for heteroatoms are common in biological and therapeutic RNAs. Important examples include the C-nucleosides pseudouridine and N1-methyl-pseudouridine; these modifications were reported to slow degradation of large RNAs, but the mechanism is unknown. We measured kinetics of thermal and enzymatic cleavage at a single bond of synthetically modified RNAs, and find that carbon substitution markedly reduces strand cleavage rates in RNA by both mechanisms. Studies of nucleophilic acylation reactions of RNAs and of small alcohols of varied p K a suggest that reduced inductive effects resulting from carbon substitution for electronegative atoms results in both higher p K a and lower nucleophilicity. The results provide insight into native transcriptome modifications as well as RNA therapies.
No takes yet. Share an insight, caveat, or question.
Banerjee et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: